Current Report Filing (8-k)
December 04 2019 - 6:06AM
Edgar (US Regulatory)
0000203527
false
0000203527
2019-12-03
2019-12-04
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported)
|
December 4, 2019
|
VARIAN MEDICAL SYSTEMS, INC.
|
(Exact Name of Registrant as Specified in its Charter)
|
Delaware
|
1-7598
|
94-2359345
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File
Number)
|
(IRS Employer
Identification No.)
|
3100 Hansen Way, Palo Alto, CA
|
94304-1030
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant's telephone number, including area code
|
(650) 493-4000
|
Not Applicable
|
(Former Name or Former Address, if Changed Since Last Report)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:
|
Trading Symbol(s)
|
Name of each exchange on which registered:
|
Common Stock, $1 par value
|
VAR
|
New York Stock Exchange
|
|
Item 7.01.
|
Regulation FD Disclosure.
|
Management of Varian
Medical Systems, Inc. (the “Company”) will use the information in the presentation slides attached hereto as
Exhibit 99.1 in meetings with institutional investors. The presentation provides investors with an update on governance
measures that the Company has implemented in the recent past.
The information included
in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 that is provided pursuant to this Item 7.01,
is being furnished and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in
any filing under the Securities Act of 1933, as amended.
|
Item 9.01.
|
Financial
Statements and Exhibits.
|
|
(d)
|
Exhibits.
|
|
|
|
|
|
The following exhibit is being furnished, and is not deemed to be filed:
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Varian Medical Systems, Inc.
|
|
|
|
By:
|
/s/ John W. Kuo
|
|
Name:
Title:
|
John W. Kuo
Senior Vice President, General Counsel and Corporate Secretary
|
Dated: December 4, 2019
Varian Medical System (NYSE:VAR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Varian Medical System (NYSE:VAR)
Historical Stock Chart
From Sep 2023 to Sep 2024